A Medicaid and Commercial Insured Claims-Based Study to Estimate Improved Antipsychotic Medication Adherence Among Patients with Schizophrenia.
Saved in:
| Title: | A Medicaid and Commercial Insured Claims-Based Study to Estimate Improved Antipsychotic Medication Adherence Among Patients with Schizophrenia. |
|---|---|
| Authors: | Pyenson, Bruce, Goldberg, Sara, Iwasaki, Kosuke, Boyarsky, Victoria, Dirani, Riad |
| Source: | Journal of Behavioral Health Services & Research. Apr2013, Vol. 40 Issue 2, p222-233. 12p. |
| Subjects: | Antipsychotic agents, Health insurance, Medicaid, Schizophrenia, Patient compliance, Epidemiology, Clinical trials |
| Abstract: | Compliance with antipsychotic medication is clinically important but challenging for schizophrenia patients. Clinical trials and epidemiological studies strongly suggest that improved compliance results in reduced hospitalizations and other adverse outcomes. Examination of Medicaid and commercial claim data suggests that a significant portion of schizophrenia patients have a regular pattern of visits with one outpatient professional, yet are noncompliant with their medication. For many of these patients, results show that the administration of once-monthly verifiable therapy would improve compliance. [ABSTRACT FROM AUTHOR] |
| Copyright of Journal of Behavioral Health Services & Research is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
Be the first to leave a comment!
